lamivudine has been researched along with Cadaver in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, FK; Chan, HL; Chui, AK; Lau, WY; Rao, AR; Wong, J | 1 |
| Huh, W; Joh, JW; Kim, DJ; Kim, JA; Kim, SJ; Kim, YG; Lee, KW; Oh, HY | 1 |
| Choi, IS; Choi, SH; Heo, JS; Joh, JW; Kim, SJ; Kim, SM; Kim, YI; Koh, KC; Lee, BB; Lee, JH; Lee, SK; Lee, WY; Paik, SW; Park, JH; Peck, KR; Sohn, TS; Song, JH | 1 |
3 other study(ies) available for lamivudine and Cadaver
| Article | Year |
|---|---|
Virological and histological outcome of a patient with chronic hepatitis B transplanted with liver from hepatitis C virus-positive donor.
Topics: Adult; Antiviral Agents; Cadaver; Carcinoma, Hepatocellular; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C; Humans; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Male; Tissue Donors | 2003 |
Cadaveric renal transplantation in hepatitis B antigen-positive recipients using hepatitis B antigen-positive donor organs with lamivudine treatment.
Topics: Adult; Antiviral Agents; Brain Death; Cadaver; Female; Hepatitis B; Hepatitis B Antigens; Histocompatibility Testing; Humans; Kidney Transplantation; Lamivudine; Liver; Male; Tissue Donors | 2004 |
Prophylaxis against hepatitis B recurrence following liver transplantation in HBs Ag(+) patients.
Topics: Adult; Antiviral Agents; Cadaver; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B Surface Antigens; Humans; Immunization, Passive; Immunoglobulins; Immunosuppressive Agents; Lamivudine; Liver Transplantation; Living Donors; Male; Middle Aged; Recurrence; Retrospective Studies; Survival Rate; Tissue Donors | 2000 |